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Much has been accomplished in identifying the mole- 
cules and genes responsible for T-cell recognition. We 
are now familiar with two distinct heterodimers, a/3 and 
~/8, and we know that the former (at least) confers on a 
T cell the ability to recognize antigens complexed with 
specific molecules of the major histocompatibility com- 
plex (MHC) (Dembic et al. 1986; Saito and Germain 
1987). Because of the recent solution of an MHC class I
structure (Bjorkman et al. 1987a,b), its apparent 
generalization to class II molecules (Brown et al. 
1988), as well as the similarity of T-cell receptor (TCR) 
primary sequences to immunoglobulins (Igs), we can 
guess a great deal about how they might interact 
(Chothia et al. 1988, Claverie et al. 1989; Davis and 
Bjorkman 1988; see also Bjorkman and Davis, this 
volume). These remain speculations, however, until we 
can derive real biochemical and structural data from 
the event itself (e.g., TCR-antigen-MHC interaction). 
This is required in order to move the current state of 
affairs beyond the inferences that we are limited to by 
the indirect nature of current assay methods. Toward 
such a biochemical resolution of this issue, we have for 
some years been attempting to express TCR 
heterodimers in a soluble form, first as immunologic 
chimerics, with limited success (Gascoigne t al. 1987), 
and more recently as lipid-linked molecules that can be 
cleaved off the surface of expressing cells (A. Lin et al. ; 
B. Devaux et al.; both in prep.). 
In contrast with the situation in the periphery, where 
the ligand for TCRs antigen-major histocompatibility 
complex (Ag-MHC) seems clear, what happens in the 
thymus with regard to T-cell repertoire selection is not 
so well understood. In investigating this area, we have 
made transgenic mice carrying TCRs of defined 
specificity (Berg et al. 1988, 1989a,b; Ivars et al. 1988; 
B. Fazekas de St. Groth et al., in prep.). In addition, 
MHC transgenics provided through a collaboration 
with C. Benoist and D. Mathis (van Ewjik et al. 1988) 
have provided an invaluable tool in characterizing some 
of the TCR/MHC interactions that must occur in the 
thymus. This has provided useful insights into both 
positive and negative selection, as discussed below. 
Although we do not yet know the precise molecules 
that may be involved, ultimately the combination of 
soluble TCRs and TCR transgenic mice should provide 
a solid basis for exploring these phenomena. One 
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scenario would be that since a particular MHC mole- 
cule is all that is required for T-cell export from the 
thymus (in the absence of nominal antigen) then a 
TCR/MHC interaction alone (or with a neutral peptide 
in the structure) may be possible. This should be de- 
tectable with a soluble receptor, and the relative affini- 
ty of such an event could serve as predictor of the fate 
of a given TCR in the thymus. 
Soluble TCR Heterodimers 
Because TCR heterodimers are assembled with the 
CD3 polypeptides to form complexes of at least seven 
polypeptides before appearing in the surface (Minami 
et al. 1987), they may be one of the more difficult types 
of molecules to produce in a soluble form. On the other 
hand, the very immunoglobulin-like character of its 
variable (V), diversity (D), joining (J), and constant 
(C) region elements, makes it very likely that it can 
bind to Ag-MHC by itself and that structurally it could 
exist and bind to its ligand in solution much like an 
antibody. Thus, the challenge has been to find condi- 
tions in which TCR chains can be expressed and form 
heterodimers free of CD3 molecules, either secreted 
from cells in culture or in a membrane-associated form 
that could be easily cleaved from the surface. Initial 
attempts in our laboratory took the form of TCR(V)- 
Ig(C) hybrids expressed in myeloma cell lines (Gas- 
coigne et al. 1987). Interestingly, only V,(TCR) 
CH(Ig ) chimeras could be assembled or secreted as 
apparently normal immunological molecules (being ex- 
pressed with light chains). Neither V~ (Gascoigne t al. 
1987), Vv, nor V~ (R. Wallich et al.; I.A. MacNeil et 
al.; both unpubl.) gene segments could be expressed in
that same context, suggesting that there is some struc- 
tural barrier to proper folding. Another category of 
TCR-Ig chimeras, namely those of Karjalainen and 
co-workers (Traunecker et al. 1989) have also failed to 
produce proper heterodimers (with one exception; B. 
Malissen, pers. comm.). Recent reports of Ig(V) 
TCR(C) chimeras being expressed and having demon- 
strable antigen-binding activity (Z. Eshhar; Y. 
Kurosawa et al.; both pers. comm.) indicate that the 
reciprocal type of chimera works well. A number of 
groups have also tried to express soluble TCRs by 
truncation, that is, by placing a stop codon at the 
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Figure 1. Schematic structure of Ptdlns (PI)-anchored protein. (A) Structure of membrane-bound DAF. During the maturation 
of DAF, the last 17 amino acids (TM), containing a highly hydrophobic domain, are proteolytically cleaved. ThePtdIns moiety is 
then attached to the cystein (C). The last 37 amino acids at he carboxyl terminus of DAF that functions as a PtdIns-anchoring 
signal are highlighted ([~). PtdIns is linked to the carboxyl terminus of DAF through glucosamine, glycan, and ethanolamine 
residues. PtdIns-PLC cleaves at the phosphodiester bond f the PtdIns moiety as indicated. (B) Structure of PtdIns-anchored 
TCR. The domain structure and disulfide bond of TCRs are indicated. In the PtdIns-anchored TCR the transmembrane and 
cytoplasmic domains are replaced with the PtdIns-anchoring si nal. PtdIns-anchored xpressed on the cell surface with the PtdIns 
moiety attached to the carboxyl terminus of the 20 amino acid residues remaining of the PtdIns-anchor signal. 
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beginning of the transmembrane s quence (O. Acuto 
and E. Reinherz; K. Arai et al., both pers. comm.). In 
these cases, it appears that polypeptides are expressed, 
but there is no heterodimer formation. This is not an 
infrequent occurrence in truncation experiments, per- 
haps because of incorrect juxtaposition f the two 
chains and/or loss of important cell-trafficking signals 
(in the transmembrane s quence). Recently, through 
colleagues at Genentech, we became aware of the in- 
creasingly large list of surface proteins known to be 
lipid-linked (for review, see Ferguson and Williams 
1988). All such proteins can be cleaved with a specific 
enzyme, phosphatidylinositol-specific-phospholipase C 
(Ptdlns-PLC), to produce soluble forms. Caras et al. 
(1987) had shown that the carboxy-terminal 37 amino 
acids of decay accelerating factor (DAF) could serve as 
the signal sequence for the lipid-linked expression of a 
herpes simplex virus membrane protein. Thus, expres- 
sion of TCR polypeptides as Ptdlns-linked molecules 
might allow them to associate in the plane of a mem- 
brane to maximize heterodimer formation and to be 
cleaved off the surface of expressing cells to produce a 
soluble form. From a suggestion of P. Travers, we also 
included experiments with the carboxyl terminus of 
human placental alkaline phosphatase (HPAP) (Kam 
et al. 1985) because that Ptdlns-linked molecule is 
normally expressed as a homodimer (DAF is a mono- 
mer). Thus, an HPAP "stem" structure may be more 
compatible with proper heterodimer formation. 
Figure 1A shows the native form of DAF with the 
glycan-Ptdlns tail. The enzyme Ptdlns-PLC cleaves as 
indicated. Figure 1B shows schematics of the TCR- 
DAF fusions with the TCR/HPAP chimeras being 
done in the same fashion. The characteristics of expres- 
sion of this type is that a proform of the molecule is 
translated and that in the endoplasmic reticulum a 
portion of the carboxyl terminus is cleaved off (17 
amino acids in the case of DAF and 23 amino acids in 
the case of HPAP; Micanovic et al. 1988) and an 
ethanolamine-carbohydrate-phosphatidylinositol link- 
age (Fig. 1A, from Ferguson and Williams 1988) is 
added to the new carboxyl terminus of the protein, 
which then makes its way to the cell surface. 
With respect o TCR expression in both COS cells 
(for transient transfections) and Chinese hamster ovary 
(CHO) cells (for long-term transfectants), we found 
that in most cases single chains of the TCR could be 
expressed with either the HPAP or the DAF signal 
sequence with high efficiency (using an expression vec- 
tor derived from pcDL-SRa296, Takebe et al. 1988) 
and cleaved off the surface of expressing cells with 
Ptdlns-PLC (in early experiments, a gift from M. Low). 
Expression could be demonstrated by either the im- 
munoprecipitation f surface-iodinated cells or fluores- 
cence-tagging and analysis by microscopy or a fluores- 
cence-activated cell sorter (FACS). Immunoprecipita- 
tion indicates the presence of both dimers and mono- 
mers in most cases (A. Linet al.; B. Devaux et al.; both 
in prep.). Analysis of CHO ceils transfected with both 
a and/3 chains from the 2B4 hybridoma modified with 
either the DAF or HPAP signal sequences was particu- 
larly revealing. As shown in Figure 2, stable transfec- 
tants could be isolated that coexpressed both a and/3 
chain determinants (A. Lin et al., in prep.). To demon- 
strate that heterodimers between a and/3 were being 
formed that juxtapose V and V~ determinants, we 
made use of the fact that preincubation of 2B4 TCR- 
bearing cells with the saturating amounts of anti-Va2B4 
(A2B4-2 from Samelson et al. 1983) antibody abolished 
staining with the anti-V~3 antibody (KJ25 from Pullen 
et al. 1988). This cross-blocking phenomenon is shown 
in Figure 3, showing /3- Jurkat cells (a gift from A. 
Weiss) transfected with normal 2B4 a and /3 chain 
genes as a control. In Figure 3A, the cells were stained 
with KJ25 (a hamster antibody) and visualized with 
fluorescinated anti-hamster antiserum. The presence of 
both negative and positive populations seen in Figure 3 
is due to the nonclonal nature of this cell line. In Figure 
3B, this same cell line has been pretreated with anti- 
2B4 (V~) antibody both prior to and during the KJ25 
staining, effectively blocking all anti-V~ reactivity. This 
same effect can be seen with CHO cells transfected 
with either a DAF and/3 DAF chimeras or a HPAP 
and/3 HPAP constructs (Fig. 3C, D), indicating that 
approximately 90% of the 2B4 /3-chain polypeptides 
are being expressed as heterodimers with the com- 
plementary a chain (A. Lin et al., in prep.). Mass 
culture, cleavage with PtdIns-PLC, and isolation on 
antibody columns also indicates that most of the TCR 
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Figure 2. Coexpression of Ptdlns-anchored TCR a and /3 
chains on the cell surface. CHO cells were transfected with a 
plasmid containing the sequences encoding TCR a and fl 
chains with PtdIns-anchor signal sequences (A. Lin et al., in 
prep.). The stable transfectants were analyzed for surface 
expression of a and fl chains, with FACS, by sequentially 
staining antibodies KJ25 (anti-V~3) and biotinylated A2B4.2 
(anti-V i1) with fluorescein-isothyocyanate (FITC)-conju- 
gated goat anti-mouse immunoglobulin and streptavidin as 
second antibodies, respectively. The data is plotted as log 
fluorescent intensity in arbitrary units. 
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Figure 3. Blocking of KJ25 by A2B4.2 on the staining of cell-surface Ptdlns-anchored TCR./3 - Jurkat with surface expression of 
functional 2B4 TCRa/3 (A and B) and CHO transfectants (C and D) (as described in Fig. 2) were stained with antibody KJ25, 
with (B and D) or without (A and B) pretreatment with A2B4.2. Following binding of FITC-conjugated goat anti-mouse 
immunoglobulin, cells were analyzed on the FACS. The data are plotted as log fluorescent intensity in arbitrary scale. CHO has 
higher fluorescent background than Jurk t as indicated in the propidium iodide staining (A. Lin et al., in prep.) 
protein expressed in this fashion is in the form of 
heterodimers (data not shown). Currently, we are able 
to purify hundreds of micrograms of soluble receptor. 
Perhaps the most crucial test is whether TCR expressed 
in this way can bind to antigen/MHC complexes. Pre- 
liminary experiments suggest that it can, but signals are 
very low and the amount of fluctuation is high. 
Selection of the T-cell Repertoire In Vivo 
How the T-cell repertoire is shaped in the thymus has 
long been an interesting but controversial rea of im- 
munology. In particular, the concept of "positive selec- 
tion" or rather the selective xport to the periphery of 
T cells that are best able to interact with self-MHC 
molecules has been the subject of much controversy. 
Whereas many laboratories have seen this type of selec- 
tion in irradiated recipient strains (Bevan 1977; Fink 
and Bevan 1978; Kappler and Marrack 1978; Sprent 
1978; von Boehmer et al. 1978; Zinkernagel et al. 1978; 
Singer et al. 1981), others have not (Matzinger and 
Mirkwood 1978; Stockinger et al. 1980; Ishii et al. 
1981). Governman et al. (1986) dismissed evidence of 
positive selection as being the result not of thymic 
selection but of preferential T-cell expansion in the 
periphery. In addition, the nature of the experiments 
performed was constrained by the facts that mice were 
heavily manipulated (e.g., irradiated); no single TCR 
could be followed but only reactivity to particular an- 
tigens that must involve many TCRs and probably 
many epitopes as well; the signal being followed is
relatively low because of the small number of cells with 
a given reactivity at any one time; and because the 
number of cells being followed is a small fraction of the 
total, the opportunity to study the biochemistry and 
physiology of this phenomenon is nil. 
The applicability of the transgenic mouse technology 
(Hogan et al. 1986) to these problems is very clear in 
that with the proper expression of a given TCRa/3 a 
large fraction of the T cells in a given individual would 
be of uniform specificity and subject to the same in- 
fluences. In this case, different MHC molecules, an- 
tigens, and other forces could all be used to modulate 
expression. The power of this approach can be seen in 
Figure 4. In this experiment, a- and fl-chain genomic 
constructs for 2B4, a helper T-cell hybridoma that rec- 
ognizes a fragment of cytochrome c complexed to the 
I-E K molecule (Hedrick et al. 1982; Samelson et al. 
1983), have been introduced into the mouse germ-line 
and back-crossed extensively to B10 mice to remove 
minor lymphocyte-stimulating a tigen (MIs-2A/3 A) el- 
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Figure 4. Staining of thymocytes from H-2 kxb versus H-2 b a/3 transgenic mice. (A) Thymocytes from an H-2 kxb (left) and an H-2 b 
(right) a/3 transgenic mouse were stained with directly conjugated anti-CD4-phycoerythrin (PE) and the anti-CD8-FITC. The 
numbers on each profile indicate he percentage of total thymocytes with each phenotype. (B) Thymocytes from an H-2 kxb 
nontransgenic control (left), an H-2 k~b a/3 transgenic ( enter), and an H-2 b a/3 transgenic (right) were stained with KJ25 (anti-V~3) 
followed by anti-hamster Texas Red plus directly conjugated A2B4-2-FITC. The number on each profile indicates the percentage 
of cells staining brightly with both a and/3 chain antibodies. (Reprinted, with permission, from Berg et al. 1989b.) 
fects (Berg et al. 1988, 1989b; Ivars et al. 1988). In this 
case, the IgH enhancer (Banerji et al. 1983; Gillies et 
al. 1983) has been used in place of the native a and/3 
enhancers to achieve a high level of expression (Berg et 
ai. 1988; Ivars et al. 1988). Figure 4A shows the very 
different CD4/CD8 thymic staining patterns of a/3 
transgenics having the appropriate MHC (H-2 k) versus 
those lacking I-E expression altogether (H-2b). Thymic 
expression on a (H-2k X H-2R)F, bK background is 
relatively normal, whereas the H-2 bBB pattern is dis- 
tinctly abnormal, with an obviously arrested develop- 
ment at the double-positive stage (CD4-8- )  of thymo- 
cyte differentiation, as indicated by the greatly reduced 
numbers of single positive (CD4. + or CD8 § thymo- 
cytes. This failure of a/3 transgene-bearing ceils to ma- 
ture in the wrong MHC environment is also seen in 
Figure 4B, in this case staining with antibodies directed 
at both chains of the TCR transgenes. Here we see that 
H-2 K individuals have a large fraction of a/3-2B4 dull 
cells (in the double-positive compartment) and also 
significant numbers of a/3 bright cells as well (corre- 
sponding to the single-positive compartment). These 
transgene-TCR dull cells are just as visible in the H-2 b 
transgenic thymus, but the bright aft-staining cells are 
not. Peripheral expression follows the same pattern, 
with H-2 z mice having many more a/3 staining cells and 
a much higher fraction of cytochrome c reactive cells 
than H-2 b littermates, as measured in limiting dilution 
interleukin-2 (IL-2) assays of antigen-naive mice (Berg 
et al. 1989b). Also of interest is the heavy bias toward 
CD4 expression seen in a/3 mice, which ave H-2 k, 
although the 2B4 hybridoma lacks CD4 (or CD8) ex- 
pression. This suggests that the original T cell express- 
ing the 2B4 antigen receptor was in fact CD4 + and that 
expression of this molecule was lost sometime after 
fusion with BW5147. In fact, very few T-cell fusions 
have persistent CD4 or CD8 expression. Together with 
the data of von Boehmer and colleagues (Kisielow et 
al. 1988b) and Loh and colleagues (Sha et al. 1988a,b) 
with class I MHC-specific transgenics preferentially ex- 
pressing CD8, this data also indicates that the MHC 
class preference of a TCR predetermines CD4 or CD8 
expression. In addition, to characterize this 
phenomenon further, we wish also to address the fol- 
lowing questions: Is the I-E molecule responsible for 
this effect? Is thymic expression of I-E necessary and 
sufficient? What cells in the thymus are most important 
for positive selection? 
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Figure 5. CD4 versus CD8 staining of thymocytes from AX and Ay a/3 transgenic mice. Thymocytes for a/3 transgenic mice of two 
MHC types (H-2 b + Ay and H-2 b + AX) were stained with anti-CD4 and anti-CD8. The percentage ofthymocytes in each subset 
is indicated on each profile. Cells were stained with directly conjugated anti-CD4-PE and anti-CD8-FITC. (Reprinted, with 
permission, from Berg et al. 1989b.) 
This we were able to do with the help of C. Benoist 
and D. Mathis, who kindly provided us with lines of 
transgenic mice for expressing different versions of 
E~ k, the gene defective in H-2 b mice and several other 
l -E-  strains (Mathis et al. 1983; Le Meur et al. 1985; 
van Ewijk et al. 1988). We will focus here on the Ay 
mice, which on a H-2 b background express I-E in the 
cortical epithelium of the thymus with approximately 
1% of normal expression in the medulla (and none 
elsewhere) and the AX mice, which express I-E only in 
the medullary region of the thymus (van Ewijk et al. 
1988). Crossing our 2B4 aft mice with these E~ k trans- 
genies produced very clear effects as shown in Figure 5. 
The first panel shows the CD4/CD8 pattern of thymo- 
cytes staining in the thymocytes of Ay BB mice, where- 
as the second shows the analogous data for AX BB 
mice. It is thus clear that I-E expression in the cortical 
epithelium is sufficient to rescue almost entirely the 
positive selection in these mice (Fig. 4A), whereas 
medullary expression has no discernible ffect (Berg et 
al. 1989b). Therefore, the basic tenets of positive selec- 
tion are upheld in that the original restricting element is 
the important molecule in mediating this effect (for 
complementary data in a class I MHC-dependent sys- 
tem, see Kisielow et al. 1988a). In addition, these 
results also offer very strong support that the experi- 
ments of Sprent and his colleagues showing the import- 
ance of thymic epithelial cells in this phenomenon (Lo 
and Sprent 1986; Singer 1988; Sprent et al. 1988) are 
vindicated. 
Negat ive  Se lec t ion  
The other major selective criterion being applied in 
the thymus involves the removal of self-reactive T cells. 
Ample evidence for this phenomenon involving the 
death of such cells has been obtained making use of the 
Mls-mediated self-reactivity model (Kappler et al. 
1987, 1988; MacDonald et al. 1988; Pullen et al. 1988; 
Pircher et al. 1989; White et al. 1989). These data are 
consistent with one another and indicate that Mls-reac- 
tive cells are absent from the mature single-positive 
population (CD4 § or CD8 § and the numbers in the 
double-positive CD4§ § compartments are not obvi- 
ously reduced. The limitations of these studies is inher- 
ent in the phenomenology of the Mls loci and the 
related Staphylococcus enterotoxin effects, which seem 
specific only for the germ-line-encoded residues of 
specific V~ molecules and apparently do not involve 
processed antigens (Janeway et al. 1989). Recent 
studies (Dellabona et al., this volume) further indicate 
that Staphylococcus enterotoxin B is not affected by 
mutations in I -A ,  which disrupt lysozyme peptide 
binding, but instead is only disrupted by mutations that 
point outward (from the putative a helix, that is, away 
from the peptide-binding groove). Thus, Mls and 
Staphylococcus enterotoxin reactivities are interesting 
phenomena, but their relevance to the problem of self- 
tolerance is questionable. 
The ability of the Mls deletion data to be generalized 
has come under further scrutiny with the advent of 
recent experiments examining the deletion of self-reac- 
tive cells in animals transgenic for self-reactive TCRs. 
In both examples, the HY + D b system (Kisielow et al. 
1988b) and the anti-L d model (Sha et al. 1988b) T cells 
bearing both a and fl TCR transgenes are specifically 
deleted from animals that express those targets, but in 
each case the thymic double-positive compartment is 
severely affected (as well as the mature single-positive 
cells). Thus, the timing of negative selection appears to 
be very early in or even before the CD4§ § compart- 
ment in those systems. In the 2B4 system, we have 
encountered our own experiences with negative selec- 
tion based on Mls reactivity, which helps to resolve 
some of these issues (Berg et al. 1989a). In particular, 
there was a quantitative removal of cells expressing a
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high level of the 2B4/3 chain because of the combina- 
tion of its V~3 component and the Mls-2g/3 g genotype 
(C3H/HeJ) of one of the parental strains (as defined by 
Abe et al. 1988; Fry and Matis 1988; Pullen et al. 1988, 
1989). We found deletion of mature 2B4 /3-positive 
cells to be evident in the thymuses of both 2B4 TCRa/3 
mice, as well as 2B4 /3 mice. What was interesting, 
however, was the very different phenotype xhibited by 
these two types of mice, both of which were undergoing 
massive and efficient negative selection. The thymic 
CD4/CD8 profile is shown in Figure 6, indicating that 
the /3 mice had a very similar arrest in the double- 
positive stage as seen in the H-2 ba/3 2B4 transgenics in 
Figure 4 or in normal mice undergoing Mls-mediated 
deletion (Kappler et al. 1987, 1988). In contrast, the a/3 
mice that deleted V~ 3 had a greatly reduced percentage 
of double-positive cells (2% of the total) and overall 
less than 1/10 of the normal number of thymocytes, 
exactly as reported previously by Kisielow et al. 
(1988b) for HY + D b and as seen in the high-expressing 
mice of Sha et al. (1988b). Figure 6 shows a histogram 
of the absolute numbers of CD4 § 8 + cells in these mice, 
making even clearer the conclusion that the presence of 
TCRa/3 transgenes greatly augments the affects of 
negative selection, perhaps by speeding up the kinetics 
of T-cell differentiation and selection in the thymus 
(Berg et al. 1989a). This, in fact, is predictable from the 
observations that the TCRa chain is the last TCR to be 
rearranged and expressed during thymic development, 
and thus the presence of a rearranged a chain is bound 
to have an effect on maturation of at least some T cells. 
In fact, data (B. Fazekas de St. Groth et al., in prep.) 
indicate that TCRa transgenics express TCRa/3 fully 2 
days before normal (day 15 versus day 17) in fetal mice 
and at inappropriately high levels. This effect may be 
due to the absence of normal controlling elements in 
experiments to date, especially the silencer egions 3' 
of Ca, recently described by Winoto and Baltimore 
(this volume). Another important point is that this 
study of negative selection shows the essential equival- 
ence of Mls-mediated deletion versus antigen plus 
MHC (Kisielow et al. 1988b) and alloreactive (Sha et 
al. 1988b) deletion in aft transgenic mice. This indicates 
that Mls-mediated eletion is, in fact, a valid model for 
the developmental spects of self-tolerance. 
A third conclusion from this study is that death by 
negative selection in aft transgenics i not the same as 
death by absence of positive selection in any of the 
three aft transgenic systems discussed above. This is 
indicated in Figure 7, which compares 2B4 aft expres- 
sion on H-2 b and H-2 k background transgenics versus 
negative selection of these same transgenes because of 
Mls-2g/3A-mediated eletion. Thus, although both 
positive and negative selection are first evident at the 
same time normally (i.e., toward the end of the double- 
positive stage of differentiation) and seem to occur in 
the same location in the thymus (i.e., the cortex), the 
effect of negative selection on aft mice is phenotypical- 
ly much more severe. One explanation for this might be 
that self-reactive aft transgenic ells arise and are dis- 
patched more quickly; the mechanism of death by 
negative selection in this instance might be kinetically 
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Figure 6. The effects of negative selection on thymocytes of a/3 versus/3 transgenic mice are shown graphically (Berg et al. 
1989a). The total number of thymocytes of each subset (CD4-8-, CD4+8 § CD4+8 -, CD4-8 § are indicated for (1) a 
nontransgenic control, (2) an anti-[D b + HY] a/3 transgenic (Kisielow et al. 1988a), (3) an anti-[H-2 k + Mls-2 a and/or -3 a] a/3 
transgenic, (4) a non-V,3 deleting a/3 transgenic, (5) ananti-[H-2 k + Mls-2 a and/or -3 a]/3 transgenic, and (6) a non-V,3-deleting/3 
transgenic. Note the severe reduction n CD4 +8 + cells in the a/3 transgenics compared with the wofold reduction (back to normal 
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much faster, mediated either by another cell type (3,6 
killers?) or by some "active" principal. Thus, a/3 trans- 
genics appear to be illustrating some significant mech- 
anistic differences between positive and negative selec- 
tion in the thymus. 
CONCLUDING REMARKS 
Much as issues involving the generation of antibody 
diversity began to be resolved in the late 1970s, the field 
of T-cell recognition and selection is beginning to 
coalesce around the specific molecules and the genes 
responsible for them. Unlike the antibody "problem," 
however, knowledge of TCR or MHC genes alone has 
not been sufficient o explain much of the phenomena 
important to the T-cell field. Instead, these issues have 
been starting points in a progressive narrowing of op- 
tions toward what we hope will be a resolution of some 
of them in the near future. The successful expression of 
soluble TCRs will help to bridge the gap between our 
essentially circumstantial knowledge of T-cell antigen/ 
MHC interactions to date and a more complete bio- 
chemical and ultimately structural appreciation for 
what is going on. More distant is the expectation that 
mice transgenic for specific TCRs will not only confirm 
and extend classical experiments on positive and nega- 
tive selection but will be the ideal departure point for 
mechanistic studies of these phenomena. 
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